You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sodium Glucose Cotransporter 2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sodium Glucose Cotransporter 2 Inhibitiors on Left Ventricular

Not yet recruiting
  • SGLT2 Inhibitiors Remodeling Effect
  • Chronic Heart Disease
  • Sodium-glucose cotransporter 2 inhibitor
  • (no location specified)
Nov 14, 2023

Cardiorenal Syndrome Trial in New Haven (Dapagliflozin)

Not yet recruiting
  • Cardiorenal Syndrome
  • New Haven, Connecticut
    Yale New Haven Hospital
Oct 26, 2023

Blood Pressure, Salt; Excess, Diabete Type 2 Trial in Pisa (Hypersodic/Hyposodic diet)

Recruiting
  • Blood Pressure
  • +2 more
  • Hypersodic/Hyposodic diet
  • Pisa, PI, Italy
    Azienda Ospedaliero-Universitaria Pisana
Aug 23, 2023

Sodium-glucose Cotransporter 2 Inhibitors+Sacubitril/Valsartan

Recruiting
  • Heart Failure
  • +2 more
  • SGLT2 inhibitor
  • Roma, RM, Italy
    Fondazione Policlinico Universitario A. Gemelli IRCSS
Jun 28, 2023

Diabetes, Cellular Senescence, Sodium-Glucose Transporter 2 Inhibitors Trial in Seoul (SGLT2 inhibitor, Glimepiride)

Not yet recruiting
  • Diabetes Mellitus
  • +2 more
  • Seoul, Korea, Republic of
    Yonsei University College of Medicine
Aug 1, 2023

MDD Trial in New York (Empagliflozin)

Not yet recruiting
  • Major Depressive Disorder
  • New York, New York
    NYU Langone Health
Feb 24, 2023

Cystinuria Trial in San Francisco (Dapagliflozin)

Not yet recruiting
  • Cystinuria
  • San Francisco, California
    University of California, San Francisco
Sep 13, 2022

PCO Trial in Bani Suwayf (Dapagliflozin 5 MG, Metformin Hydrochloride 1000 MG, Dapagliflozin/Metformin)

Recruiting
  • PCO
  • Dapagliflozin 5 MG
  • +2 more
  • Banī Suwayf, Beni Suef, Egypt
    Beni-suef university
Oct 26, 2022

Epilepsy Trial in Saint Louis (Empagliflozin 25 mg, Placebo)

Recruiting
  • Epilepsy
  • Empagliflozin 25 mg
  • Placebo
  • Saint Louis, Missouri
    Washington University
Aug 20, 2022

(NIS) on Sodium-glucose Co-transporter-2 Inhibitors Use in

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Sodium/glucose cotransporter-2 inhibitors (SGLT2i)
  • (no location specified)
May 22, 2023

SGLT2 Inhibition in Heart Failure

Recruiting
  • Heart Failure
  • Sodium-glucose cotransporter 2 inhibitor
  • Belfast, United Kingdom
    Belfast Health and Social Care Trust
Nov 15, 2023

Tricuspid Regurgitation Trial in Seoul (Dapagliflozin Propanediol Hydrate 12.3 mg)

Recruiting
  • Tricuspid Regurgitation
  • Dapagliflozin Propanediol Hydrate 12.3 mg
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jan 9, 2023

Fatty Liver Disease Trial in Tainan (Canagliflozin 100mg)

Completed
  • Fatty Liver Disease
  • Canagliflozin 100mg
  • Tainan, Taiwan
    National Cheng Kung University Hospital
Feb 28, 2023

Acute Heart Failure Trial in Cairo (Dapagliflozin 10mg Tab)

Active, not recruiting
  • Acute Heart Failure
  • Dapagliflozin 10mg Tab
  • Cairo, Egypt
    Kasr Al-Ainy Medical School
Aug 24, 2023

GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • Myocardial Infarction
  • PCI
  • Naples, Italy
    Celestino Sardu
Aug 31, 2023

Fatty Liver, Nonalcoholic Trial (SGLT2 inhibitor)

Not yet recruiting
  • Fatty Liver, Nonalcoholic
  • SGLT2 inhibitor
  • (no location specified)
Oct 31, 2023

SGLT-2 Inhibitors in the Treatment of Ascites

Recruiting
  • Ascites Hepatic
  • +2 more
  • SGLT2 inhibitor
  • Palermo, Italy
  • +1 more
Aug 11, 2023

IgA Nephropathy, Immunoglobulin A Nephropathy Trial (Atrasentan, Placebo)

Not yet recruiting
  • IgA Nephropathy
  • Immunoglobulin A Nephropathy
  • (no location specified)
Apr 27, 2023

Sleep Apnea Trial in New Haven, Cleveland (Ertugliflozin 15 mg, Placebo)

Not yet recruiting
  • Sleep Apnea
  • Ertugliflozin 15 mg
  • Placebo
  • New Haven, Connecticut
  • +1 more
Jan 24, 2023

Heart Failure With Reduced Ejection Fraction Trial in Porto (Sacubitril-valsartan, SGLT2 inhibitor)

Recruiting
  • Heart Failure With Reduced Ejection Fraction
  • Porto, Portugal
  • +3 more
Aug 9, 2023

Diabetes, Type 2, Endothelial Dysfunction Trial in Boston (Dapagliflozin, Placebo)

Recruiting
  • Diabetes Mellitus, Type 2
  • Endothelial Dysfunction
  • Boston, Massachusetts
    BU School of Medicine Evans 748
Jun 1, 2022

Transthyretin Amyloid Cardiomyopathy Trial in New York (Empagliflozin)

Recruiting
  • Transthyretin Amyloid Cardiomyopathy
  • New York, New York
    Columbia University Irving Medical Center / NewYork-Presbyterian
Mar 15, 2022

Deformation Imaging by Strain in Chronic Heart Failure Over

Recruiting
  • Sodium-GLucose coTransporter-2 Inhibitors
  • Heart Failure With Reduced Ejection Fraction
  • Sodium-GLucose coTransporter-2 inhibitors
  • Siena, Italy
    UOC Diagnostica Cardiovascolare, AOU Senese Policlinico Le Scott
May 5, 2022

Heart Failure With Preserved Ejection Fraction Trial in Porto (Dapagliflozin, Spironolactone, Spironolactone + Dapagliflozin)

Recruiting
  • Heart Failure With Preserved Ejection Fraction
  • Porto, Portugal
  • +1 more
Jan 12, 2023

Cystinuria Trial in San Francisco (Dapagliflozin)

Recruiting
  • Cystinuria
  • San Francisco, California
    University of California, San Francisco
Oct 4, 2022